Characterization of the Oligomerization and Aggregation of Human Serum Amyloid A

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Patke, Sanket ^a,b   Srinivasan, Saipraveen ^b   Maheshwari, Ronak ^b   Srivastava, Sunit K ^b   Aguilera, J Javier ^b,c   Colón, Wilfredo ^b,c   Kane, Ravi S ^a,b  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c Rensselaer Polytechnic Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; METHIONINE; SERUM AMYLOID A;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; ATOMIC FORCE MICROSCOPY; CIRCULAR DICHROISM; FLUORESCENCE SPECTROSCOPY; IMMUNOBLOTTING; IN VITRO STUDY; INCUBATION TEMPERATURE; MEASUREMENT; OLIGOMERIZATION; PROTEIN AGGREGATION; PROTEIN DEFECT; PROTEIN FOLDING; PROTEIN STABILITY; SOLUBILITY;

HUMANS; METHIONINE; MODELS, MOLECULAR; PROTEIN ISOFORMS; PROTEIN MULTIMERIZATION; PROTEIN REFOLDING; PROTEIN STRUCTURE, SECONDARY; SERUM AMYLOID A PROTEIN; SOLUBILITY;

EID: 84878657649     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064974     Document Type: Article

References (48)

1. Rocken C, Shakespeare A, (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Archiv 440: 111-122.
2. Uhlar CM, Whitehead AS, (1999) Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry 265: 501-523.
3. Urieli-Shoval S, Linke RP, Matzner Y, (2000) Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Current Opinion in Hematology 7: 64-69.
4. Tape C, Tan R, Nesheim M, Kisilevsky R, (1988) Direct Evidence for Circulating ApoSAA as the Precursor of Tissue AA Amyloid Deposits. Scandinavian Journal of Immunology 28: 317-324.
5. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN, (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358: 24-29.
6. Chambers RE, Macfarlane DG, Whicher JT, Dieppe PA, (1983) Serum Amyloid A Protein Concentration in Rheumatoid-Arthritis and Its Role in Monitoring Disease-Activity. Annals of the Rheumatic Diseases 42: 665-667.
7. Eriksen N, Benditt EP, (1980) Isolation and Characterization of the Amyloid-Related Apoprotein (SAA) from Human High-Density Lipoprotein. Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences 77: 6860-6864.
8. Benditt EP, Eriksen N, (1977) Amyloid Protein SAA Is Associated with High-Density Lipoprotein from Human-Serum- (Apolipoproteins). Proceedings of the National Academy of Sciences of the United States of America 74: 4025-4028.
9. Kisilevsky R, Subrahmanyan L, (1992) Serum Amyloid A Changes High-Density-Lipoproteins Cellular Affinity- a Clue to Serum Amyloid-as Principal Function. Laboratory Investigation 66: 778-785.
10. Kisilevsky R, Tam SP, (2002) Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease. Pediatric Pathology & Molecular Medicine 21: 291-305.
11. Tam SP, Flexman A, Hulme J, Kisilevsky R, (2002) Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. Journal of Lipid Research 43: 1410-1420.
12. Hirakura Y, Carreras I, Sipe JD, Kagan BL, (2002) Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense. Amyloid-Journal of Protein Folding Disorders 9: 13-23.
13. Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS, (1994) Evolution of the Serum Amyloid-a (Saa) Protein Superfamily. Genomics 19: 228-235.
14. Malle E, Steinmetz A, Raynes JG, (1993) Serum Amyloid A (SAA)- an Acute-Phase Protein and Apolipoprotein. Atherosclerosis 102: 131-146.
15. Sipe J, (1999) Part 2- Revised nomenclature for serum amyloid A (SAA). Amyloid-International Journal of Experimental and Clinical Investigation 6: 67-70.
16. Liepnieks JJ, Kluvebeckerman B, Benson MD, (1995) Characterization of Amyloid-a Protein in Human Secondary Amyloidosis- the Predominant Deposition of Serum Amyloid-A1. Biochimica Et Biophysica Acta-Molecular Basis of Disease 1270: 81-86.
17. Sletten K, Husby G, Natvig JB, (1976) Complete Amino-Acid Sequence of an Amyloid Fibril Protein Aa1 of Unusual Size (64 Residues). Biochemical and Biophysical Research Communications 69: 19-25.
18. Parmelee DC, Titani K, Ericsson LH, Eriksen N, Benditt EP, et al. (1982) Amino-Acid-Sequence of Amyloid-Related Apoprotein (Aposaa1) from Human High-Density Lipoprotein. Biochemistry 21: 3298-3303.
19. Ather JL, Ckless K, Martin R, Foley KL, Suratt BT, et al. (2011) Serum Amyloid A Activates the NLRP3 Inflammasome and Promotes Th17 Allergic Asthma in Mice. Journal of Immunology 187: 64-73.
20. Bozinovski S, Uddin M, Vlahos R, Thompson M, McQualter JL, et al. (2012) Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proceedings of the National Academy of Sciences of the United States of America 109: 935-940.
21. Cai H, Song CJ, Endoh I, Goyette J, Jessup W, et al. (2007) Serum amyloid A induces monocyte tissue factor. Journal of Immunology 178: 1852-1860.
22. Westermark GT, Engstrom U, Westermark P, (1992) The N-Terminal Segment of Protein Aa Determines Its Fibrillogenic Property. Biochemical and Biophysical Research Communications 182: 27-33.
23. Kinkley SM, Bagshaw WLG, Tam SP, Kisilevsky R, (2006) The path of murine serum amyloid a through peritoneal macrophages. Amyloid-Journal of Protein Folding Disorders 13: 123-134.
24. Kisilevsky R, Manley PN, (2012) Acute-phase serum amyloid A: Perspectives on its physiological and pathological roles. Amyloid-Journal of Protein Folding Disorders 19: 5-14.
25. Quist A, Doudevski I, Lin H, Azimova R, Ng D, et al. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 102: 10427-10432.
26. Banka CL, Yuan T, Debeer MC, Kindy M, Curtiss LK, et al. (1995) Serum Amyloid-a (Saa)- Influence on Hdl-Mediated Cellular Cholesterol Efflux. Journal of Lipid Research 36: 1058-1065.
27. Hosoai H, Webb NR, Glick JM, Tietge UJF, Purdom MS, et al. (1999) Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice. Journal of Lipid Research 40: 648-653.
28. Yamada T, Kluve-Beckerman B, Liepnieks JJ, Benson MD, (1994) Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta. 1226: 323-329.
29. Cheng N, He R, Tian J, Ye PP, Ye RD, (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. Journal of Immunology. 181: 22-26.
30. He RL, Zhou J, Hanson CZ, Chen J, Cheng N, et al. (2009) Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 113: 429-437.
31. Patke S, Maheshwari R, Litt J, Srinivasan S, Aguilera JJ, et al. (2012) Influence of the Carboxy Terminus of Serum Amyloid A on Protein Oligomerization, Misfolding, and Fibril Formation. Biochemistry 51: 3092-3099.
32. Srinivasan S, Patke S, Wang Y, Ye Z, Litt J, et al. (2013) Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2. J Biol Chem 288: 2744-2755.
33. Srinivasan R, Jones EM, Liu K, Ghiso J, Marchant RE, et al. (2003) pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia. J Mol Biol 333: 1003-1023.
34. Ladiwala ARA, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, et al. (2010) Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid A beta into Off-pathway Conformers. Journal of Biological Chemistry 285: 24228-24237.
35. Wang Y, Srinivasan S, Ye ZQ, Aguilera JJ, Lopez MM, et al. (2011) Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer. Biochemical and Biophysical Research Communications 407: 725-729.
36. Wang LM, Colon W, (2005) Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer. Protein Science 14: 1811-1817.
37. Wang LM, Lashuel HA, Colon W, (2005) From hexamer to amyloid: Marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature. Amyloid-Journal of Protein Folding Disorders 12: 139-148.
38. Ye ZQ, Poueymiroy DB, Aguilera JJ, Srinivasan S, Wang Y, et al. (2011) Inflammation Protein SAA2.2 Spontaneously Forms Marginally Stable Amyloid Fibrils at Physiological Temperature. Biochemistry 50: 9184-9191.
39. Levine H, (1993) Thioflavine-T Interaction with Synthetic Alzheimers-Disease Beta-Amyloid Peptides- Detection of Amyloid Aggregation in Solution. Protein Science 2: 404-410.
40. Klunk WE, Jacob RF, Mason RP, (1999) Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay. Anal Biochem 266: 66-76.
41. McCubbin WD, Kay CM, Narindrasorasak S, Kisilevsky R, (1988) Circular-dichroism studies on two murine serum amyloid A proteins. Biochem J 256: 775-783.
42. Digambaranath JL, Dang LA, Dembinska M, Vasyluk A, Finke JM, (2010) Conformations within Soluble Oligomers and Insoluble Aggregates Revealed by Resonance Energy Transfer. Biopolymers 93: 299-317.
43. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.
44. Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, et al. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Molecular Neurodegeneration 2: 18.
45. Wang LM, Lashuel HA, Walz T, Colon W, (2002) Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel. Proceedings of the National Academy of Sciences of the United States of America 99: 15947-15952.
46. Patel H, Bramall J, Waters H, De Beer MC, Woo P, (1996) Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 318 (Pt 3): 1041-1049.
47. Wang LM, Colon W, (2007) Effect of zinc, copper, and calcium on the structure and stability of serum amyloid A. Biochemistry. 46: 5562-5569.
48. Noborn F, Ancsin JB, Ubhayasekera W, Kisilevsk R, Li JP, (2012) Heparan Sulfate Dissociates Serum Amyloid A (SAA) from Acute-phase High-density Lipoprotein, Promoting SAA Aggregation. Journal of Biological Chemistry 287: 25669-25677.